A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells

被引:143
作者
Colonna, M
Nakajima, H
Navarro, F
López-Botet, M
机构
[1] Basel Inst Immunol, CH-4005 Basel, Switzerland
[2] Univ Madrid, Hosp Princesa, Serv Immunol, Madrid 28006, Spain
关键词
human; cell surface molecules; major histocompatibility complex monocytes/macrophages; dendritic cells;
D O I
10.1002/jlb.66.3.375
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We review what is presently known about structure, cellular distribution, biochemical characteristics, and function of a new family of human cell-surface receptors referred to as immunoglobulin-like transcripts (ILTs), leukocyte Ig-like receptors (LIRs), or monocyte/macrophage Ig-like receptors (MIRs), These receptors are genetically, structurally, and functionally related to a group of natural killer (NK) cell receptors for HLA class I molecules known as killer cell Ig-like receptors (KIRs), Distinct ILT/LIR/MIR isotypes are differentially expressed on lymphocytes, monocytes, macrophages, dendritic cells, and granulocytes; at least some of them recognize HLA class I molecules. Whereas some isotypes either inhibit or induce cell activation, others may be secreted as soluble receptors. ILT/LIR/MIR receptors may allow all immune cells to monitor class I expression on other cells and to respond in its absence, just as NK cells do. In addition, they may contribute to homeostasis by establishing activation thresholds that can be overcome only by relevant triggering stimuli and not by bystander cells.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 65 条
  • [41] Minskoff SA, 1998, J IMMUNOL, V161, P2079
  • [42] Moretta A, 1998, CURR TOP MICROBIOL, V230, P15
  • [43] MORTON HC, 1995, J BIOL CHEM, V270, P29781
  • [44] Nakajima H, 1999, J IMMUNOL, V162, P5
  • [45] Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO
  • [46] 2-4
  • [47] Olcese L, 1997, J IMMUNOL, V158, P5083
  • [48] PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228
  • [49] PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X
  • [50] PULFORD K, 1991, CLIN EXP IMMUNOL, V85, P429